Background: Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist.
Objective: To provide evidence-based consensus recommendations for patients with HS in seven special patient populations: i) pregnancy, ii) breastfeeding, iii) pediatrics, iv) malignancy, v) tuberculosis infection, vi) hepatitis B or C infection, and vii) HIV disease.
Reclamation of petroleum-polluted environments is a key issue for today and in the future, as our reliance on oil will persist for decades. An eco-friendly solution is to use microbes that play a role in petroleum-hydrocarbon degradation. However, as hydrocarbon degradation involves a multi-step process involving different functional groups, focusing only on finding efficient bacterial species will not be the complete solution.
View Article and Find Full Text PDFPurpose: Rare diseases substantially contribute to population morbidity and mortality. Understanding rare disease health-related quality of life (HRQL) is essential for evaluating platform-based interventions that aim to tackle multiple rare diseases at a time. However, most HRQL studies focus on single or select group of rare diseases, often in a single country.
View Article and Find Full Text PDFJACC Cardiovasc Interv
December 2024
J Racial Ethn Health Disparities
December 2024
Hidradenitis suppurativa (HS) is a debilitating and understudied inflammatory skin disease that disproportionately impacts Black Americans. The objective of this study was to explore the role that race and ethnicity may play in HS patients' perceptions of physician bias and their care quality. We administered a cross-sectional anonymous online survey to individuals with HS from June 13 to 30, 2021.
View Article and Find Full Text PDF